Bone Biologics Corp
About Bone Biologics Corp
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2020
- $1.1B
- Net income
- -$3.1M
- Total assets
- $5.8M
- Market cap
- $2.2M
Source: SEC EDGAR · updated Jun 8, 2026
- Market cap
- $2.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 27, 2015
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Bone Biologics Corp.